BioCentury
ARTICLE | Company News

Illumina, GlaxoSmithKline genomics news

March 12, 2012 7:00 AM UTC

A jury in the U.S. District Court for the District of Delaware found that Illumina's Genome Analyzer System infringes U.S. Patent No. 6,107,023. LadaTech LLC, which is jointly owned by GlaxoSmithKline...